Ultragenyx Pharmaceutical (RARE) Operating Leases (2019 - 2025)
Ultragenyx Pharmaceutical (RARE) posted Operating Leases of $24 million for Q4 2025, down 20.0% from $30 million a year earlier but up 10.6% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Operating Leases (2019 - 2025) Analysis & Trends
Since Q4 2019, Ultragenyx Pharmaceutical has reported Operating Leases for 24 quarters.
- Annual Operating Leases shows a five-year compound annual growth rate of -9.4% (FY2020 to FY2025).
- In prior years, Ultragenyx Pharmaceutical's Operating Leases was $30 million in FY2024 (-1.9%), $30.57 million in FY2023 (+54.3%), $19.81 million in FY2022 (-35.9%) and $30.9 million in FY2021 (-21.3%).
- Quarterly Operating Leases has run from a low of $14.85 million in Q2 2023 to a high of $36.75 million in Q1 2021 over five years.
- On a year-over-year basis, Operating Leases has declined in each of the last six quarters, with growth averaging 8.5% over the last eight quarters.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q2 2024, with growth of 73.4%; the weakest was Q2 2023, with a decline of 42.7%.
- According to Business Quant data, Operating Leases for the three prior quarters was $21.69 million (Q3 2025), $24.53 million (Q2 2025) and $27.79 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.51 Bn | -292.70 Mn | 180.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 24.00 Mn |
| Sep 30, 2025 | 21.69 Mn |
| Jun 30, 2025 | 24.53 Mn |
| Mar 31, 2025 | 27.79 Mn |
| Dec 31, 2024 | 30.00 Mn |
| Sep 30, 2024 | 23.66 Mn |
| Jun 30, 2024 | 25.74 Mn |
| Mar 31, 2024 | 27.98 Mn |
| Dec 31, 2023 | 30.57 Mn |
| Sep 30, 2023 | 34.56 Mn |
| Jun 30, 2023 | 14.85 Mn |
| Mar 31, 2023 | 17.34 Mn |
| Dec 31, 2022 | 19.81 Mn |
| Sep 30, 2022 | 22.87 Mn |
| Jun 30, 2022 | 25.90 Mn |
| Mar 31, 2022 | 28.04 Mn |
| Dec 31, 2021 | 30.90 Mn |
| Sep 30, 2021 | 33.34 Mn |
| Jun 30, 2021 | 35.86 Mn |
| Mar 31, 2021 | 36.75 Mn |
API Access
Ultragenyx Pharmaceutical Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();